Focus on Future Medicine and Genetics
About This Show
Where will medicine be ten years from now? ReachMD explores this broad-ranging question with a look ahead to pivotal breakthroughs that will transform healthcare: conquering cancer without debilitating side effects, unleashing fat-fighting nucleic acids, advancing technologies in the operating room, and ‘switching off' obesity genes responsible for the development of chronic diseases.
Most Recent Episode
Pharmacometabolomics to Predict Statin Response: Ready for Prime Time?
Oct 2 16
Host: Alan S. Brown, MD, FNLA
Live from the Clinical Lipid Update of the National Lipid Association in Amelia Island, FL, host Dr. Alan Brown welcomes Dr. Rhoda Cooper-DeHoff. Dr. Cooper-DeHoff is an Associate Professor in the Department of Pharmacotherapy and Translational Research and Division of Cardiovascular Medicine of the Colleges of Pharmacy and Medicine at the University of Florida. She is also Associate Director of the Center for Pharmacogenomics at this institution. Dr. Cooper-DeHoff discusses the rise of pharmacometabolomics, genomic testing, and pharmacogenetic testing in lipidology, with particular emphasis on predictive mapping for statin responses.